Glytec, LLC
Lobbying client
Glytec is a healthcare technology company that makes FDA-cleared insulin management software, including its Glucommander dosing system, used by hospitals to manage blood glucose in patients. The company has filed 15 lobbying disclosures in New York City since 2024, paying Greenberg Traurig LLP and O'Donnell & Associates $195,000 to lobby three council members, Julie Menin, Lynn C. Schulman and Mercedes Narcisse, on budget funding for an insulin management platform and on procurement of software for NYC Health + Hospitals.
- Council members lobbied
- 3
- Filings (since 2024)
- 15
- Lobbying compensation (since 2024)
- $195,000
Lobbied these council members
- Lynn C. Schulman Council Member, District 29 (Queens)
- Mercedes Narcisse Council Member, District 46 (Brooklyn)
- Julie Menin Council Member, District 5 (Manhattan)
Represented by lobbyist firms
- Greenberg Traurig, LLP Lobbyist firm
- O'Donnell & Associates, LLC Lobbyist firm
What they lobbied on
subjects from their filings
- Budget - Insulin Management Platform
- Procurement - NYC Health & Hospitals Software
- Procurement - issues related to healthcare and technology